Recent Updates
Recently added Catalysts
ANIK Positive Sentiment Score: 70/100

Anika to Participate in the Sidoti Small Cap Virtual Investor Conference

Key Takeaway: Anika Therapeutics, Inc. has announced its participation in the Sidoti Small Cap Virtual Investor Conference set for September 21, 2023. The management will host a virtual presentation followed by a Q&A session at 10:45 AM ET. This initiative highlights Anika's commitment to transparency and investor relations while showcasing its advancements in orthopedic care, specifically in joint preservation.

Market Sentiment Analysis

POSITIVE FACTORS

  • Anika Therapeutics will participate in a significant investor conference, showcasing its commitment to investor engagement.
  • The company's focus on joint preservation and innovative orthopedic solutions highlights its dedication to advancing healthcare.
  • Virtual presentation format allows broader access for investors and stakeholders.

Full Press Release Details

BEDFORD, Mass., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate in the Sidoti Small Cap Virtual Investor Conference on Thursday, September 21, 2023. Anika will host a virtual presentation with Q&A starting at 10:45am ET.
Webcast of the presentation and Q&A will be available in the Investor Relations section of Anika’s website, www.anika.com. An archive of the presentation will also be available on the website.
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.
ANIKA, ANIKA THERAPEUTICS and the Anika logo are registered trademarks of Anika Therapeutics, Inc.
For Investor Inquiries:
Anika Therapeutics, Inc.
Mark Namaroff, 781-457-9287
Vice President, Investor Relations, ESG and Corporate Communications

Frequently Asked Questions

What is Anika Therapeutics known for?

Anika Therapeutics specializes in joint preservation and early intervention orthopedics.

When is Anika's virtual investor conference?

The conference is on September 21, 2023, starting at 10:45am ET.

Where can I watch Anika's conference presentation?

The presentation can be viewed in the Investor Relations section of Anika’s website.

What areas does Anika focus on in orthopedics?

Anika focuses on Osteoarthritis Pain Management, Regenerative Solutions, and more.

Where is Anika Therapeutics headquartered?

Anika Therapeutics is headquartered near Boston, Massachusetts.

Last updated: Sep 12, 2023